• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CAN 0.00% 6.2¢

CANN GROUP LIMITED - Charts / Financials

Cann Group Limited is an Australia-based company that is focused on developing,... Cann Group Limited is an Australia-based company that is focused on developing, producing, and supplying innovative cannabis medicines. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. The Company supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. It also owns Satipharm and its patent-protected capsule technology. The Company's research, cultivation and good manufacturing practices (GMP) manufacturing facilities are located in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 03/05/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
0 0.0¢ 0   0 0.0¢ 0

Directors & Senior Management

Dr. Julian John Chick Chairman of the Board
Mr. Tony di Pietro Chief Financial Officer, Joint Company Secretary
Mr. Shane Duncan Chief Operating Officer
Ms. Jenni Pilcher Executive Director
Mr. Steven Notaro Company Secretary
Mr. Robert Barnes Director
Mr. Douglas John Rathbone Non-Executive Director
Mr. John Sharman Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
6.2¢
Change
0.000(0.00%)
Mkt cap ! $27.12M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.